Introduction
Many biological processes rely on the formation of proteinprotein complexes. These interactions are potentialt herapeutic targets,b ut their diversity presents as ignificant challenge to the development of small-molecule inhibitors. [1] These challenges are mainly due to proteins being relatively large and having interaction surfaces that are, relative to enzyme active sites, frequently rather featureless, and which often rely on interactions involving noncontiguous amino acids. Moreover,i n contrastt ot he case for many enzymes and protein transmembrane channels, activity-based assays cannot usually be used to identify inhibitors. [2] Despite these challenges, progress is being made in targeting protein-protein interactions (PPIs). [3] One of the methods showing significant promise is fragmentbased ligand discovery, in which binding fragments (M r < 300 Da) are identified through biophysical screens ande laborated into more potent molecules using structure-based ligand design. [4] In addition to the general challenges of PPIs, there is also the potentiali ssue of site selectivity.M any target proteins interact with an umber of different partners and may possess multiple interaction sites. These problemso fp romiscuous binding and multiple sites increase the risk of inhibitors also disrupting beneficial interactions. [5] The nuclear transporter karyopherin-a/importin-a,w hich is of increasing interesta sa na nticancera nd antiviral drug target, [6] exemplifies many of these problems. In addition to having an essential role in mediating the import of cargo proteins into the nucleus by binding to nuclear localisation signals (NLSs) that are generally specific clusters of positivelyc harged amino acids, [7] importin-a also regulates the functiono ft he non-motor spindle assembly factor TPX2 (target protein for Xenopus kinesin-like protein 2). Importin-a is ab anana-shaped protein that is constructed from as eries of 10 repeating structural motifs called armadillo repeats;i tb inds both the NLSs of nuclear import cargo proteins and TPX2 using sites on its inner concaves urface. All NLSs bind to the major binding site, spanning armadillo repeats 1-4, and some also have as mall additional contribution from the minor site, spanning repeats 6-8. [8] TPX2, however, binds primarily to the minor site of importin-a,t herebyo ffering an opportunity for selectivity.
Both the major and minor sites on importin-a interactw ith unstructured peptides on either NLSs or TPX2, which is in contrast to many other PPIs in which both partners are structured, as observed, for example, with p53 or Bcl-x L ,inwhich the binding motif is based on an a-helix.
[9] Interactions based on such unstructured peptides are more challenging to target, but some progress has been described for the BRCA2-RAD51 interaction, forexample. [10] TPX2 is essential for the formation of an ordered spindle and successful mitosis, [11] and its regulation by importin-a is the major component of RanGTP-mediated spindle assembly (Figure 1) , ap rocess on which cancer cells rely more heavily than other cells. [12] As the transport and mitotic roles of imporProtein-protein interactions are difficult therapeutic targets, and inhibiting pathologicallyr elevant interactions without disrupting other essential ones presentsa na dditional challenge. Herein we report how this might be achieved for the potential anticancer target, the TPX2-importin-a interaction. Importina is an uclear transport protein that regulates the spindle assembly protein TPX2. It has two binding sites-majora nd minor-to which partners bind. Mostnuclear transport cargoes use the major site, whereas TPX2 binds principally to the minor site. Fragment-based approaches were used to identify small molecules that bind importin-a,a nd crystallographic studies identified al ead series that was observed to bind specifically to the minor site, representing the first ligands specific for this site. Structure-guided synthesis informed the elaboration of these fragments to explore the source of ligand selectivity between the minor and major sites. These ligands are startingp oints for the development of inhibitors of this protein-protein interaction.
tin-a employt wo different sites on the protein, the TPX2-importin-a interaction has potentiala sa na nticancer target, provided selectivity fort he minor site over the major site can be achieved. Previous work had focused on establishing the consensus peptide sequence KRXF/Y/W [13] for recognition of the minor site over the major site, [14] but no small molecules have yet been designed specifically for this site. Herein we present af ragment-based approach to the development of the first site-specific ligands of the minor site TPX2-importin-a interaction and provide validation for this approach to targeting complex proteins such as importin-a.
Results and Discussion
Identification of importin-a bindingfragments by ligandobservedNMR screening of at hermal-shift-enriched library Previous reports have shown that the hit rate for PPIs is typically lower than for enzyme targets, leadingt ot he development of modified versions of fragment-screening cascades to minimise the amount of false negatives andp ositives. [10] For TPX2-importin-a,a1248-member 'rule-of-three'-compliant [15] fragment library was screened using fluorescence-based thermal shift [16] to generate an enriched libraryo f1 40 compounds. To preventt he autoinhibition that is crucial for expelling NLSs in the nucleus, an importin-a construct (DIBB-importin-a)w as used from which the importin-b binding domain (IBB) had been excised. [14] Compounds were excluded from the enriched library if they were shown to denature or aggregate the protein at room temperature, or otherwise give strong negative thermals hifts, as these may otherwise have generated false positives in subsequent ligand-observed NMR experiments. The enriched 140-fragment library was screened by the orthogonal ligand-observed NMR techniques saturation transfer difference (STD), [17] water-ligand observed via gradients pectroscopy( WaterLOGSY) [18] and Carr-Purcell-Meiboom-Gill (CPMG) spin-echo train sequence. [19] From the 140 compounds, 78 showed binding to importin-a,o fw hich 35 showed displacementb ya20-residue minor site binding TPX2 peptide (K d = 350 nm)i na tl east one technique, suggestingt hat these fragments were binding the TPX2 binding site on importin-a.
As an earlys tudy of the structure-activity relationship, 15 commercial compounds with scaffold similarity to 1 (as the fragment showing the largest changes in binding and displacement signals across all three ligand-observed NMR techniques; see Supporting Information Figure S1 ) were screened, identifying afurthernine compounds with good binding anddisplacement, giving at otal of 44 fragments (structures listed in Supporting Information Ta bleS1). The 44 potentiali mportina minor site binding fragments identified in these screens were then ranked by competitive isothermal titration calorimetry (ITC). [20] As both thermal shift and NMR experiments were performed at pH 8.0, competitive ITCs were also conducted at this pH;h owever,a ll but two fragments (6 and 10)s howed only very weak (> 15 mm competitive K d )o rn oc ompetition with the TPX2 minor site binding peptide( Supporting Information Ta ble S2). To prioritise compounds for crystallography, competitive ITC experiments were then performed at pH 6.0, the pH to be used for the crystallographic soakingt rials, removingt hose that were not soluble to 10 mm in the ITC buffer.F rom these studies 10 fragments (compounds 1-10) Figure 1 . Schematic of the role of importin-a and RanGTPint he regulation of TPX2. In mitosis, after the nuclearm embranehas been disassembled, RanGTPism aintained at high concentrationint he vicinity of chromatin. In distal regions, Ran is predominantly in the GDP-boundform, leading to agradient of RanGTP concentration. RanGDPdoes not bind importin-b,a llowing it to bind the autoinhibitoryIBB domainofi mportin-a that exposes the NLS binding sites, and so allows importin-a to sequester and inhibit TPX2 activity.T his ternary complex remainss table until it diffuses into the high concentration of RanGTPnear the chromosomes, where RanGTPb inds to importinb,r eleasing the IBB domainand displacing TPX2, which thereby becomes active,a llowing for site-specific spindle assembly. were shown to have K d 10 mm at pH 6.0 (Table 1) and were prioritised for structuralstudies.
Structure of compound 1s hows selectivebindingtot he minor site through Glu396
Fragments 1-10 were individually soaked into unliganded crystals of importin-a.X -ray datasets of resolution between 2.2 and 2.5were collected for all except forf ragments 9 and 10. Inspection of the electron density maps only showedc leard ifferencee lectron density for fragment 1,w hich was refinedt o 2.4 r esolution. Attempts to co-crystallise the remaining fragments under av ariety of conditions were unsuccessful (Supporting Information). Significantly,t he co-crystal structure of importin-a with fragment 1 revealed difference density for the compound only in the minor site of importin-a with no significant density peaks in the major site, suggesting that the initial fragment demonstrated considerable site selectivity (Figure 2A ). Fragment 1 binds in the key minor site 'hot spot' positioned such that the pyridine nitrogen atom is within hydrogen bonding or salt-bridge distance (2.8 ) of the carboxylate group of the defining minor site residue Glu396 (where the crucial arginine of TPX2 also forms interactions;F igure 2B-D). The aromatic rings of the fragment form a p-p stackingi nteraction with Trp399, with the pyridine ring overlapping the indole nitrogen ring at ad istance of 3.3 a nd an angle of 1018,a nd the phenyl ring overlaying edges with the indole phenylr ing at ad istance of 3.3 a nd an angle of 1438.T he p-p stacking interaction between both rings of the fragment and the Trp399 indole resultsinatwist between the fragment aromatic rings with atorsion angle of 388 ( Figure 2E ).
Fragment merging with TPX2 lysine
After studying the overlay of fragment 1 on the previously reported TPX2-importin-a structure, [14] compound 11 was synthesised by merging the fragment with the lysine of the key tetrapeptide KRXF/Y/W consensus sequence for TPX2 via an amine linker using ar eductive amination approach. Direct ITC at pH 6.0 gave a K d value of 4.0 mm for 11,amodest increase on the K d value of 8.7 mm for fragment 1.T ou nderstand how 11 was binding, ac o-crystal structure of it bound to importina ( Figure 3A )w as determined to 2.5 . This showed that 11 maintained the key pyridine Glu396 interaction as for compound 1 (2.8 ) as well as maintaining the p-p stacking interaction with Trp399 (the pyridine ring again overlapping the indole nitrogen ring at ad istance of 3.5 a nd an angle of 968 and the phenyl ring overlaying edges with the indole phenyl ring at ad istance of 3.3 and an angle of 1188). These changes resulti nagood overlay of the fragment portion of 11 with the structure of 1 (Supporting Information Figure S2) ; once again the torsion angle between the two aromatic rings was 408 similar to fragment 1 (388), suggesting the lysine was able to reach the new pocket without changing the fragment orientation. This suggests that the fragment, despite its low affinity,i sag ood anchor in this key hotspot. As for the structure of 1,t here was no density in the importin-a major site for 11, suggesting that the new ligand maintains specificity to the minor site. The structure of 11 showedr easonable density for the amine of the lysine group, indicating that it is reaching the desired pocket and forming ah ydrogen bond with the carbonyl group of Gly323 (3.0 ). Despite these additional interactions, the increasei na ffinity of 11 for importin-a was modest, possibly due to the alternative orientation of the lysine backbone (~1608 flip) relative to the native TPX2 peptide (Figure 3A) .
Extending the peptide chain
To assess whether the orientation of the lysine backbone in 11 was important, and to probe other interactions in the minor site, al onger merged peptide of the form fragment-KGTF 12 (with glycine replacingt he arginine, the interaction of which is mimicked by the N-terminal fragment and the TF from human [30] B) Fragment 1 (yellow)with the 2F o ÀF c density shown contouredaround the ligand at 1.0 s (blue mesh) bound to the importin-a minor site (green ribbon and sticks). C) Fragment 1 bound to the importin-a minor site without electron density.D )Fragment 1 structure overlaid with the key TPX2 residues (magenta) from the TPX2-importina crystal structure 3KND. [14] E) Schematictos how the key interactions with fragment 1:r ed residues make hydrogen bonding or salt-bridge contacts, blue residues are involved in p-p stacking interactions, and residues denoted by black circles form nonpolari nteractions with the ligand.
ChemMedChem 2015, 10,1232 -1239 www.chemmedchem.org TPX2) was synthesised and its binding analysed. Direct ITC of 12 at pH 6.0 gave a K d value of 3.3 mm,s howing no improvement on 11.T he co-crystal structure of 12 bound to importina was determined to 2.3 r esolution ( Figure 3B) . Analysis of the ligand conformation revealed that the extended peptide had caused the lysine backbonet ou ndergo a~1508 flip to orient with the native TPX2 tetrapeptide, while the fragment maintained its interaction with Glu396 (hydrogen bondingd istance of 2.8 ) andT rp399 (p-p stacking distance of pyridine to indole 3.3 w ith an angle of 948;F igure 3B and Supporting Information FigureS2). Comparing the lysine of 12 with that of 11 and TPX2, there is closer alignmentw ith TPX2, as the lysine amine makes hydrogen bonds to the carbonyls of Val321 and Asn361a nd the hydroxy group of Thr328r ather than the carbonyl of Gly323. In addition, the interactions with the peptide backbonem ade by the side chains of Asn361a nd Trp357 are the same as observed for the peptide. However the phenylalanine of 12 is poorly defined and appearst ob ei nahydrophobic pocket defined by Lys353 and Glu354 as opposed to forming p-cation stacking interactions with Arg315 as for the aromatic residue of TPX2. These differences in the alignment of the peptide backboneo f12 compared with the TPX2 represent ap otential explanation for its relativelym odest affinity ( Figure 3B ).
Removal of the phenyl ring of the biaryl scaffold
To explore the effect of changing the biaryl fragment scaffold, an unnatural amino acid incorporating ap yridine was synthesised and coupled to give the peptidic KXTF 13.D irect ITC of 13 gave a K d value of 3.9 mm,a nalogoust o12.T he 2.1 r esolution structure of 13 bound to importin-a revealed am uch better structuralo verlayo ft he peptideb ackbone with that of TPX2 than 12,w ith the exceptiono ft he phenylalanine that remains poorly defined. As with previousc ompounds,t he pyridine maintains the interactions with Glu396 (hydrogen bond 3.0 ) and Trp399 (p-p stacking distance of pyridine to indole 3.2 w ith an angle of 898), even without the biaryl scaffold ( Figure 4C ). Strikingly,f or the first time in this study,a nalysiso ft he major site showedc lear density for another molecule of 13 binding ( Figure 4A ). The interaction at the major site involved inducing a6 1 8rotation of Trp184 and a1 378 rotation of Trp231,f orming ac ryptic pocket with ad epth of~2.7 ( Figure 4D) . The pyridine of 13 fills this new cryptic pocket forming face-to-face p-p stacking interactions with Trp184 and Trp231,a td istances of 3.3 and 3.4 , respectively ( Figure 4D ). The rotation of Trp184 also opens ah ydrophobic 'shelf'o n which the phenylalanine of 13 is positioned to form edge-toface interactions with Trp184 (3.6 ) andT rp142 (3.7 ). This result was highly surprising, as no aromatic or hydrophobic containing peptides have been found to bind the major site withoutl ong chains of basic flanking residues either side of the central tetrapeptide, with classical major site cargoes having NLSs typified by the SV40 sequence ( Figure 4F) . [21] In addition, this suggested that the biaryl scaffold was as ource of selectivity for compounds 1, 11,a nd 12,a si ts rigidity presumably prevents the pyridine from orientingt oo pen the cryptic pocket as well as introducing another unfavourable aromatic into ap olar region of the major site that cannotb e maskedb yother aromatic residues of the protein.
Linker SAR increases potency and structures identify anew pocket in the minor site
Having established that the biaryl scaffold appears to be the source of selectivity for the minor site in this series of compounds, the crystal structures and docking results were used to design av ariety of compounds to explore the structure-activity relationship (SAR) of various fragment-lysine connectivities. The aim was to minimise the strain around the lysine linkage, allowing the backbone flip and improving potency ( Table 2 ). The amide-linked compound 14 had K d > 10 mm by direct ITC, suggesting that its decreased flexibility wasd eleterious. Changing the stereoisomer 15 of the lysine gave no change in affinity relative to 11,w hereas moving the lysine from the para to the meta positiono ft he phenyl ring of the biaryl 16 gave am odest improvement in potency.T oe xplore other vectors for the lysine while maintaining similarity to the Figure 3 . Structures of compounds A) 11 andB)12 bound to the minor site of importin-a.T op:l igand (yellow)with the 2F o ÀF c density showncontoured around the ligand at 1.0 s (blue mesh) bound to the importin-a minor site (green ribbon and sticks). Middle:l igand bound in minor site without density.B ottom:l igand structure overlaid with the key TPX2 residues (magenta) from the TPX2-importin-a crystal structure 3KND. [14] ChemMedChem 2015, 10,1232 -1239 www.chemmedchem.org phenyl, the second ring was replaced with at hiophene (in 17) resultinginafurther increase in potencya nd the first sub-millimolar compound. X-ray co-crystal structures were solved for all the compounds 14-17 bound to importin-a with resolution in the range of 2.0-2.6 s howing the resultant changes in lysine positionand backbone alignment ( Figure 5 ).
The inclusion of abiaryl scaffold in all cases resulted in selectivity for the minor site, and overlay with the originalf ragment 1 suggested that these remained 'anchors' for the Glu396 interaction despite the changes to the lysine (Supporting Information Figure S2 ). Both 16 and 17 showedb inding in as econd pocket of the minor site with an extra compound forming a p-p stacking interaction with Trp357 (3.4 and 4.0, respectively) and aw ater-mediated hydrogen bond to Glu354 (2.4 t ow ater then 2.9 t og lutamate, and 2.0 t ow ater then 2.8 t og lutamate, respectively), in addition to binding in the Glu396 pocket. In both cases the density for the lysinep ortion of this second compound was unresolved. For the ligands interacting with Glu396, although the fragment portions of (yellow)with the 2F o ÀF c density bound to the importin-a minor (C) and major (D) sites(top);l igand bound in minor (C) and major (D) sitesw ithout density (bottom). E) Compound 13 structure in minor site overlaid with the key TPX2 residues (magenta) from the TPX2-importin-a crystal structure 3KND. [14] F) Compound 13 structure overlaid with the key SV40 residues (cyan) from the SV40-importin-a structure, 1EJL. [30] Grey residues show the positionsoft he tryptophansi nthe SV40 structure.
ChemMedChem 2015, 10,1232 -1239 www.chemmedchem.org both 16 and 17 overlay well, the lysines behaveq uite differently.W hile the lysine amine of 17 forms hydrogen bonds with the carbonyls of Val321 (2.9 ) and Gly323 (3.2 ) in the lysine pocket,t hat of 16 does not reach into the lysine pocket, but insteadr eorients toward the solvent due to the interaction of the amide with the side chain of Asn403 via aw ater-mediated hydrogen bond (2.4 t hen 3.5 ). Such changesp erhaps explain the small differences in potencyo bserved between these compounds. Despite the changes in interaction, the increasesi na ffinity remainm odesta nd suggest that the lysine may not make as great acontribution to affinity as was indicated from previousstudies with peptide ligands. [13, 21] Finally,t he two compounds of 16 and 17 seen binding in close proximity in the importin-a minor site in their co-crystal structures could permit novel fragment linking or growing strategies, between the two biaryl binding sites, moving away from the more flexible lysine and potentially increasing affinity for the minor site.
Conclusions
PPIs are potential targets in aw ide range of diseases, but targeting interactions that are based on unstructured peptides remains asignificant challenge, in addition to the problems associated with achieving sufficient specificity.T he potentiala nticancer target interaction between TPX2 and importin-a provides ap latform for ap ilot study for the use of fragmentbased ligand discoverya gainst such targets. Al igand-observed NMR screen of at hermal-shift-enriched fragment library identified several importin-a binding fragments that appeared to bind in the minor site. Structural studies showedt hat, despite its low affinity,f ragment 1 bound specifically in the minor site of importin-a at the key residueG lu396. Information from this structure, as well as docking studies, facilitatedt he synthesis of arange compounds to probe the contributions made by different groups to affinity for the minor site binding pocket.I tw as shown that the biaryl scaffold of the fragment is key to the specificity of the compounds for the minor site over the major site, as well as showing that the lysine pocket of the minor site may not make as large ac ontribution to binding affinity as was thought from previous peptide-based studies.T hese findings are important considerations for the further development of probesand inhibitors of the TPX2-importin-a site.
These results provide ap roof of concept for the use of af ragment-screening cascade in targeting specific sites on multiple site proteins, even when they are based on the binding of unstructured peptides. We have shown fragments to be useful probesi ni dentifying the key binding interactions of open PPI sites as wella sa chieving and explaining specificity for one site over another.F urthermore, the structures showed that the fragment portion of all the compounds maintained the key interaction with Glu396 despite changes in the lysine or largerp eptide positioning, highlighting the effectiveness of fragments as anchors in key PPI hot spots.
Experimental Section
Fragment library design:T he fragment library consisted of 1248 commercial fragments based around ac ore of compounds from Maybridge, supplemented by as election of compounds chosen to maximise chemical functionality from commercial suppliers Acros Organics, Apollo Scientific, and Sigma-Aldrich. Fragments were stored as 100 mm solutions in [D 6 ]DMSO 96-well stock plates.
Protein expression and purification:T he protein construct used in this study is at runcated form of Mus musculus importin-a1 (KPNA2, Accession code:N M_010655) covering residues 70-529, lacking the N-terminal IBB domain: DIBB-importin-a. [14, 22] The protein has > 97 %s equence similarity with the Homo sapiens variant (Supporting Information Figure S4 ). The protein was expressed from an in-house modified pET-30a plasmid (EMD Bioscience) with aT EV cleavable His 6 /S-tag that was cleaved during purification;f ull details are given in the Supporting Information.
Thermal shift fragment library enrichment:T he changes in the thermal shift of importin-a caused by fragments were assessed using either aR oche LightCycler with opaque PCR plates and clear plastic sealing film (Roche) or on aB io-Rad Thermocycler with clear PCR plates and flat cap strips (Bio-Rad). Sypro Orange (5000 s olu- www.chemmedchem.org tion, Invitrogen) was diluted 1:2000 in standard buffer (50 mm Tris·HCl pH 8.0, 200 mm NaCl, 1mmDTT) before addition of importin-a to ac oncentration of 2 mm and filling assay wells to av olume of 100 mL. The standard Tris buffer was selected from ab uffer screen, as it showed the greatest thermal stabilisation of importina.F ragments were screened at af inal concentration of 5mm with 5% DMSO. The fluorescence readout was monitored from 35-60 8C (LightCycler) or 25-60 8C( Thermocycler), both at 0.01 8Cs
À1
.A ll samples were measured in duplicate. Fragments with an egative thermal shift greater than twice the negative standard deviation of each plate's negative controls wells (5 %D MSO) were removed from the enriched library.
Ligand-observed NMR screening:T he three ligand-observed techniques-STD, CPMG, and WaterLOGSY-were performed on either aB ruker Avance 500 MHz with TCI cryoprobe or on aB ruker Avance7 00 MHz spectrometer with aT XI cryoprobe. All samples were made to atotal volume of 200 mLand added to 3mmcapilla-ry tubes (Bruker) before inserting into standard or thick-walled NMR tubes (Bruker). All samples were made to volume in standard protein buffer with 10 %D 2 Oa nd 20 mm TSP.S creens were conducted with fragments at 2mm from [D 6 ]DMSO stock plates, giving af inal DMSO concentration of 2%.B inding was determined on observation of ac hange in fragment signals in the presence of 20 mm importin-a,r elative to ac ontrol sample containing only buffer and no protein. If found to bind importin-a,adisplacer sample was made by addition of 40 mm TPX2 (IIKPFNLSKGKKRTF-DEAAS) peptide (Designer Bioscience) direct to the protein sample and displacement noted if the fragment signals showed ar eturn to those seen in the control sample.
Isothermal titration calorimetry:A ll experiments were performed on aM icrocal ITC200 instrument (GE Healthcare) at 25 8C. All ITCs were performed at pH 6.0 using ITC buffer (100 mm citrate pH 6.0, 200 mm NaCl, 10 %D MSO). Fragment ITCs were performed using the competitive ITC technique following the procedure and formula described by Zhang et al. [20] (Supporting Information). Briefly,t he titration of 200 mm 20-amino acid TPX2 to 25 mm importin-a 10 % DMSO at pH 6.0 (average K d = 1.0 mm)w as compared directly with the same titration in the presence of the fragment at 5o r1 0mm. Direct ITCs were performed for elaborated compounds at pH 6.0 in ITC buffer titrating 10 mm compound into 25 mm protein. Compounds that showed double binding in crystal structures (13, 16 , and 17)h ad their ITCs fitted using ao ne-site binding model, as this gave the best curve fitting, suggesting the second binder remains relatively weak. Experimental parameters are described fully in the Supporting Information.
Crystallisation and crystallographic methods:C rystals of unliganded DIBB-importin-a were grown using hanging-drop vapour diffusioni n2 4-well Linbro plates (Hampton Research) with 4 mL drops of 100 mm DIBB-importin-a1a t1 :1 protein/precipitant volume ratio (optimal precipitant conditions:0 .1 m citrate pH 6.0, 1.05-1.20 m ammonium sulfate, 20-40 mm DTT) and streak-seeding from an DIBB-importin-a seed crystal plate 18 ha fter sealing the wells. Crystals reached their maximum size after 1-2 weeks, when they were soaked in solutions of fragment (100 mm or saturating concentration) in crystallisation buffer supplemented with 10 % DMSO for between 30 min and 5h.C rystals were then briefly exposed to crystallisation buffer (with half fragment concentration and an additional 10 %g lycerol) as ac ryoprotectant and flash cooled at 100 Ki nl iquid nitrogen. X-ray data were collected at the Diamond Light Source or European Synchrotron Radiation Facility. All datasets were processed and reduced using XDS [23] and AIM-LESS. [24] The unit cells of these crystals were sufficiently close to that of murine DIBB-importin-a1i nt he Xenopus-mouse TPX2-importin-a structure; [14] PDB ID 3KND) to enable rigid body refinement, after which coordinates were refined using iterative cycles of PHENIX, [25] CCP4, [26] and COOT. [27] Electron density maps were then inspected for difference density corresponding to the soaked ligands, which were then built into the model manually using COOT, with restraints generated in PHENIX.T he resulting models were further refined with CCP4 or PHENIX,a sw ell as adding waters and ions from the crystallisation conditions. The stereochemistry of the structure was finally assessed using MolProbity. [28] Molecular graphics were generated using the PyMOL Molecular Graphics System, version 1.6.0.0, Schrçdinger LLC. Data collection and refinement statistics are shown in Ta ble S3 of the Supporting Information. Attempts at co-crystallisation are described in the Supporting Information.
Compound docking:A ll compounds were docked into an unliganded structure of mouse DIBB-importin-a1. The protein was prepared in Discovery Studio Visualizer (Release 3.5, Accelrys Software Inc.,S an Diego, CA, USA) by removal of crystallographic waters and addition of hydrogens before selecting the coordinates of the key minor site residue Glu396. Compounds to be docked were loaded as .mol files into Discovery Studio Visualizer where hydrogens and relevant charges were added before the structures were minimised to relax bond lengths and fix bond angles. Ligands were docked into the protein in ar adius of 13 a round Glu396 using GOLD 5.1 [29] using default slow docking settings with 25 runs for each ligand. Figures of the ten lowest-energy docked positions of each were exported and subjected to visual analysis.
Synthetic chemistry:G eneral directions for the synthesis of the compounds described as well as their spectroscopic analyses are supplied in the Supporting Information. The purity of all compounds tested for binding to importin-a was assessed by LCMS or HPLC and is > 95 %unless otherwise stated.
Accession numbers:T he coordinates and structure factors for the mouse-mouse TPX2-importin-a structure used to inform compound synthesis, as well as importin-a compound structures 1, 11, 12, 13, 14, 15, 16,and 17 have been deposited in the RCSB Protein Data Bank (www.pdb.org) under the PDB ID codes:4 U54, 4U5L, 4U5N, 4U5S, 4U58, 4U5O, 4U5U, and 4U5V respectively.
